[prevalence Of Hbsag, Anti-hbc And Anti-hcv In Blood Donor Candidates At The Campinas Hemocenter].

dc.creatorGonçales Júnior, F L
dc.creatorBoccato, R S
dc.creatorPedro, R de J
dc.creatorPapaiordanou, P M
dc.creatorde Souza, C A
dc.creatorGonçales, N S
dc.creatorPellegrino Júnior, J
dc.date
dc.date2015-11-27T12:18:15Z
dc.date2015-11-27T12:18:15Z
dc.date.accessioned2018-03-29T00:50:51Z
dc.date.available2018-03-29T00:50:51Z
dc.identifierRevista Do Instituto De Medicina Tropical De São Paulo. v. 35, n. 1, p. 45-51
dc.identifier0036-4665
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/7506445
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/193675
dc.identifier7506445
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1293908
dc.descriptionAmong 29833 donors evaluated we have found a prevalence of 1.52% for HBsAg and 11% for anti-HBc. The co-positivity anti-HBc/anti-HBs in 2783 donors HBsAg negative/anti-HBc positive was 81.9%. The prevalence for HBsAg is low among Campinas donors, while anti-HBc presents high prevalence when compared to that of other countries. The anti-HCV detection in blood donors of Campinas has shown a positivity of 2.6% which is much higher than that of USA and Europe. About 36% of the anti-HCV positive donors are anti-HBc reagent, leading to the conclusion that these two viruses infect simultaneous or sequentially Brazilian blood donors.
dc.description35
dc.description45-51
dc.languagepor
dc.relationRevista Do Instituto De Medicina Tropical De São Paulo
dc.relationRev. Inst. Med. Trop. Sao Paulo
dc.rightsaberto
dc.rights
dc.sourcePubMed
dc.subjectBlood Donors
dc.subjectBrazil
dc.subjectHepacivirus
dc.subjectHepatitis Antibodies
dc.subjectHepatitis B Core Antigens
dc.subjectHepatitis B Surface Antigens
dc.subjectHepatitis C Antibodies
dc.subjectHumans
dc.title[prevalence Of Hbsag, Anti-hbc And Anti-hcv In Blood Donor Candidates At The Campinas Hemocenter].
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución